FDA adds Guillain-Barré syndrome warning to GlaxoSmithKline’s shingles vaccine

FDA adds Guillain-Barré syndrome warning to GlaxoSmithKline’s shingles vaccine

Source: 
Endpoints
snippet: 

The FDA late Wednesday sent out a safety communication to explain that while GlaxoSmithKline’s shingles vaccine Shingrix is a safe vaccine, it’s now added a new warning to the label noting an increased risk of a rare but debilitating disorder known as Guillain-Barré syndrome (GBS).